Observational research on sodium glucose co‐transporter‐2 inhibitors: A real breakthrough?

Podobne knjige/članki

• Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
  od: Raschi, Emanuel, et al.
  Izdano: (2020)
• Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
  od: Fadini, Gian Paolo, et al.
  Izdano: (2019)
• Stroke, Migraine and Triptans: From Bedside to Bench
  od: Raschi, Emanuel, et al.
  Izdano: (2016)
• Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System
  od: Raschi, Emanuel, et al.
  Izdano: (2021)
• Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment
  od: Raschi, Emanuel, et al.
  Izdano: (2020)